Best Oculomotor Endpoints for Clinical Trials in Hereditary Ataxias: A Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital‑Motor Biomarkers. [PDF]
Pretegiani E +16 more
europepmc +1 more source
Nigrostriatal Degeneration Underpins Sensorimotor Dysfunction in an Inducible Mouse Model of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). [PDF]
Kul E, Santos M, Stork O.
europepmc +1 more source
Tyrosine Peptides Alleviates Multifaceted Toxicity Linked to Expanded CGG Repeats in Fragile X‑Associated Tremor/Ataxia Syndrome. [PDF]
Singh K +4 more
europepmc +1 more source
Mis-spliced FMR1 transcripts in human fragile X syndrome neural progenitors and neurons. [PDF]
Hourani SM +4 more
europepmc +1 more source
Personalized Follow Up and Genetic Diagnosis Update of FMR1-Related Conditions: A Change in Diagnosis, Prognosis and Expectations. [PDF]
Roche-Martínez A +5 more
europepmc +1 more source
Semantic and Syntactic Language Differences Associated with the <i>FMR1</i> Premutation Genotype. [PDF]
Friedman L +3 more
europepmc +1 more source
Parkinson's Disease Polygenic Risk Score and Neurological Involvement in Carriers of the FMR1 Premutation Allele: A Case for Genetic Modifier. [PDF]
Loesch DZ +9 more
europepmc +1 more source
Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder associated with premutation alleles of the fragile X mental retardation 1 (FMR1) gene.
Flora Tassone, Claudia M Greco
exaly +2 more sources
Related searches:
The variable phenotype of FXTAS
Neurology, 2005Fragile X syndrome (FXS) is the most common inherited cause of mental retardation. It is caused by an expansion of a CGG trinucleotide repeat in the 5′ untranslated region of the fragile X mental retardation gene, the FMR1 gene, on the X chromosome to more than 200 repeats (full mutation).
Christoph Kamm, Thomas Gasser
openaire +1 more source

